ARCHIVES

BMS Execs Knew Of Flaws In ImClone Plan For C225 Prior To $2-Billion Licensing Deal

This article is from The Cancer Letter archive.

Vol. 28 No. 25 | June 21, 2002

Download PDF Visit The Full Archive

Related Articles

Nixon Resignation Won’t Hurt Cancer Program, Might Lead To More Money; Weinberger Stays

August 16, 1974

Patient Advocates Ask HCFA To Clarify Coverage Decision.

September 8, 2000

New Research Grant Awards

October 18, 1974

Letters To the Editor: NCI director Broder responds To Kopans On Mammography

October 8, 1993

In Brief: Caplan Receives NSB Public Service Award

March 28, 2014

Beefed Up Centers Subcommittee Meets On Core Guidelines

December 2, 1977